PCI Biotech Holding ASA

BATS-CHIXE:PCIBO Stock Report

Market Cap: NOK 80.3m

PCI Biotech Holding Management

Management criteria checks 4/4

PCI Biotech Holding's CEO is Ronny Skuggedal, appointed in Oct 2013, has a tenure of 9.17 years. total yearly compensation is NOK2.13M, comprised of 78.3% salary and 21.7% bonuses, including company stock and options. directly owns 0.15% of the company’s shares, worth NOK118.25K. The average tenure of the management team and the board of directors is 9.2 years and 5.6 years respectively.

Key information

Ronny Skuggedal

Chief executive officer

NOK 2.1m

Total compensation

CEO salary percentage78.3%
CEO tenure9.2yrs
CEO ownership0.1%
Management average tenure9.2yrs
Board average tenure5.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Ronny Skuggedal's remuneration changed compared to PCI Biotech Holding's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2022n/an/a

-NOK 73m

Jun 30 2022n/an/a

-NOK 84m

Mar 31 2022n/an/a

-NOK 88m

Dec 31 2021NOK 2mNOK 2m

-NOK 88m

Sep 30 2021n/an/a

-NOK 90m

Jun 30 2021n/an/a

-NOK 90m

Mar 31 2021n/an/a

-NOK 100m

Dec 31 2020NOK 3mNOK 1m

-NOK 72m

Sep 30 2020n/an/a

-NOK 71m

Jun 30 2020n/an/a

-NOK 64m

Mar 31 2020n/an/a

-NOK 61m

Dec 31 2019NOK 2mNOK 1m

-NOK 89m

Sep 30 2019n/an/a

-NOK 68m

Jun 30 2019n/an/a

-NOK 62m

Mar 31 2019n/an/a

-NOK 43m

Dec 31 2018NOK 2mNOK 1m

-NOK 35m

Sep 30 2018n/an/a

-NOK 46m

Jun 30 2018n/an/a

-NOK 48m

Mar 31 2018n/an/a

-NOK 48m

Dec 31 2017NOK 1mNOK 1m

-NOK 43m

Sep 30 2017n/an/a

-NOK 34m

Jun 30 2017n/an/a

-NOK 33m

Mar 31 2017n/an/a

-NOK 35m

Dec 31 2016NOK 1mNOK 1m

-NOK 32m

Sep 30 2016n/an/a

-NOK 34m

Jun 30 2016n/an/a

-NOK 34m

Mar 31 2016n/an/a

-NOK 31m

Dec 31 2015NOK 1mNOK 1m

-NOK 32m

Compensation vs Market: Ronny's total compensation ($USD213.14K) is below average for companies of similar size in the UK market ($USD348.41K).

Compensation vs Earnings: Ronny's compensation has been consistent with company performance over the past year.

CEO

Ronny Skuggedal (46 yo)

9.2yrs

Tenure

NOK 2,127,000

Compensation

Mr. Ronny Skuggedal has been the Chief Financial Officer at PCI Biotech Holding ASA and PCI Biotech AS since joining in October 2013. He serves as Chief Executive Officer at PCI Biotech Holding ASA since S...

Leadership Team

NamePositionTenureCompensationOwnership
Ronny Skuggedal
CEO & CFO9.2yrsNOK 2.13m0.15%
NOK 118.3k
Anders Høgset
Chief Scientific Officer14.9yrsNOK 1.71m0.17%
NOK 139.3k
Kristin Eivindvik
Chief Development Officer3.8yrsNOK 607.00k0.068%
NOK 54.2k
Lucy Wabakken
Acting CDOno dataNOK 1.46mno data

9.2yrs

Average Tenure

61yo

Average Age

Experienced Management: PCIBO's management team is seasoned and experienced (9.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Hilde Steineger
Independent Director3.6yrsNOK 200.00k0.021%
NOK 17.2k
Hans Bohn
Independent Chairman7.6yrsNOK 355.00k0.33%
NOK 265.9k
Lars Viksmoen
Independent Director6.6yrsNOK 220.00k0.035%
NOK 27.9k
Christina Herder
Independent Director7.6yrsNOK 220.00k0.027%
NOK 21.5k
Andrew Hughes
Independent Director4.6yrsNOK 220.00kno data
Hilde Furberg
Independent Director3.6yrsNOK 220.00kno data

5.6yrs

Average Tenure

62.5yo

Average Age

Experienced Board: PCIBO's board of directors are considered experienced (5.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/12/06 13:32
End of Day Share Price 2022/09/08 00:00
Earnings2022/09/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PCI Biotech Holding ASA is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hans BohnBeringer Finance AB